Dr. Mark Campbell
"The technology behind new treatment options progresses every day — oncologists need help to leverage these advances for their patients' battle with cancer."
Empowering community oncologists with the latest therapeutic and molecular services
The right drug, at the right time, at the right place...in your community
Intervention Insights provides actionable strategies that assist community oncologists in developing personalized treatments for their patients. By analyzing cancerous tissue, we generate a complete genomic picture of over 20,000 genes and corresponding molecular pathways that uniquely define a person’s cancer and the drugs that target them. We deliver this information to our frontline oncology partners who can quickly review hundreds of drugs which specifically target the molecular basis of a person’s cancer.
Intervention Insights was created to support our community oncology partners with the best information for their patients' fight against cancer.
Our Difference
Each person deserves the best possible support, compassion, and respect as they fight their battle with cancer.
We provide our oncology partners with the latest molecularly targeted information specific to their patient’s disease.
Become an Oncology Partner
We are building a network of front line, community-based oncology partners because this is where the battle against cancer is fought.
Our dedicated team is committed to fully support our oncology partners in treating their patients' cancer with patient specific pharmacogenomic information.
News & Highlights
How OncInsights™ Works
With the explosion of information in the emerging fields of personalized medicine and pharmacogenomics comes an amazing opportunity for advancements in understanding of cancer treatments as well as the challenge of organizing all the information. Read More…
Personalized Argument
Just as each person is genetically unique, each individual's cancer has its own molecular profile that defines how it grows, how it progresses and how it responds to various treatments. Read More…
Collaborators
It is essential that we collaborate with the leaders on all fronts: research, community oncology, pharmacology, and clinical application. In order to provide the latest advances in personalized medicine, we are continuiously learning — focusing on cancer biology and therapeutics. Read More…